Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.7.7.7 extracted from

  • Stern, H.R.; Sefcikova, J.; Chaparro, V.E.; Beuning, P.J.
    Mammalian DNA polymerase kappa activity and specificity (2019), Molecules, 24, 2805 .
    View publication on PubMedView publication on EuropePMC

Protein Variants

Protein Variants Comment Organism
A329A not meaningfully associated with breast cancer risk; more likely to respond to Pt-based chemotherapy Homo sapiens
A471V moderate decrease in activity Homo sapiens
D189G impaired for extension step of TLS Homo sapiens
E292K similar activity as wild-type enzyme Homo sapiens
E29K decreased insertion opposite abasic site (2-20) Homo sapiens
E419G 20fold decrease in kcat/Km on dG and 670fold decrease on N2-CH2-Anth-dG, extension defect Homo sapiens
E430G low activity on AP site Homo sapiens
E449K low activity on AP site, low fidelity Homo sapiens
F155S decreased activity on model abasic site Homo sapiens
F192C slight increase in activity with N2-furfuryl-dG-containing templates Homo sapiens
G154E decreased activity opposite model abasic site, pathogenic Homo sapiens
I39T similar activity to WT with several types of DNA damage Homo sapiens
L21F 30fold decrease in incorporation opposite N2-CH2-(9-anthracenyl)-dG (N2-CH2-Anth-dG) Homo sapiens
L442F low activity on AP site Homo sapiens
P169T slight decrease in activity on undamaged DNA Homo sapiens
R219I slight decrease in activity Homo sapiens
R246X 5-10fold less active with 8-oxo-dG-, N2-CH2-Anth-dG-, O6-Me-dG- and abasic-containing templates Homo sapiens
R298H less active than wild-type on several different lesions Homo sapiens
R512W decreased activity on undamaged and damaged DNA Homo sapiens
S423R 1.6fold more effcient than wild-type, 2fold increased DNA binding affinity, pathogenic Homo sapiens
T44M lesion-specific reduction in activity. Reduced activity with N2-CH2-Anth-dG, O6-Me-dG and abasic sites Homo sapiens
T473A decreased activity on undamaged and damaged DNA Homo sapiens
V130I mutant has relaxed discrimination against the major groove adduct N6-furfuryl-dA Homo sapiens
Y432S less active on undamaged and damaged DNA, extension defect, decreased DNA binding affinity Homo sapiens

Inhibitors

Inhibitors Comment Organism Structure
MK886
-
Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens Q9UBT6
-
-

Synonyms

Synonyms Comment Organism
DNA polymerase kappa
-
Homo sapiens

General Information

General Information Comment Organism
drug target the enzyme is an attractive target for cancer therapies because it has been correlated with a shorter survival time in patients with glioblastoma as well as poor chemotherapy responses in some cases Homo sapiens
malfunction many cancer-associated single-nucleotide polymorphisms have been reported in the Pol kappa gene, some of which are associated with poor survival and altered chemotherapy response Homo sapiens
physiological function the enzyme has roles both in maintaining and compromising genomic integrity. The expression of pol kappa is altered in several different cancer types, which can lead to genome instability Homo sapiens